Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice

Brain Research

Volumn 1417, Issue , 2011, Pages 127-136

  Zeitlin, Ross ^a   Patel, Sagar ^a   Burgess, Sarah ^a   Arendash, Gary W ^c   Echeverria, Valentina ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer's disease; Amyloid ; CREB; Neurodegeneration; Transgenic mouse

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CAFFEINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SERINE; STRESS ACTIVATED PROTEIN KINASE;

ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; NERVE CELL PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALZHEIMER DISEASE; ANIMALS; BLOTTING, WESTERN; BRAIN; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MAP KINASE KINASE 4; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SIGNAL TRANSDUCTION;

MUS; MUS MUSCULUS;

EID: 80053221873     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.08.036     Document Type: Article

References (52)

1. G.E. Alexander, M.R. DeLong, and P.L. Strick Parallel organization of functionally segregated circuits linking basal ganglia and cortex Annu. Rev. Neurosci. 9 1986 357 381 (Pubitemid 16055790)
2. G.W. Arendash, W. Schleif, K. Rezai-Zadeh, E.K. Jackson, L.C. Zacharia, J.R. Cracchiolo, D. Shippy, and J. Tan Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production Neuroscience 142 2006 941 952 (Pubitemid 44740473)
3. G.W. Arendash, T. Mori, C. Cao, M. Mamcarz, M. Runfeldt, A. Dickson, K. Rezai-Zadeh, J. Tan, B.A. Citron, X. Lin, V. Echeverria, and H. Potter Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice J. Alzheimers Dis. 17 2009 661 680
4. A. Barco, C. Pittenger, and E.R. Kandel CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects Expert Opin. Ther. Targets 7 2003 101 114 (Pubitemid 36204592)
5. H. Bito, and S. Takemoto-Kimura Ca(2+)/CREB/CBP-dependent gene regulation: a shared mechanism critical in long-term synaptic plasticity and neuronal survival Cell Calcium 34 2003 425 430 (Pubitemid 37021234)
6. H. Braak, and E. Braak Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes J. Neuropathol. Exp. Neurol. 49 1990 215 224 (Pubitemid 20155922)
7. J.J. Brightwell, C.A. Smith, R.L. Neve, and P.J. Colombo Transfection of mutant CREB in the striatum, but not the hippocampus, impairs long-term memory for response learning Neurobiol. Learn. Mem. 89 2008 27 35 (Pubitemid 350102251)
8. P.J. Colombo, J.J. Brightwell, and R.A. Countryman Cognitive strategy-specific increases in phosphorylated cAMP response element-binding protein and c-Fos in the hippocampus and dorsal striatum J. Neurosci. 23 2003 3547 3554 (Pubitemid 36531998)
9. P.J. Colombo Learning-induced activation of transcription factors among multiple memory systems Neurobiol. Learn. Mem. 82 2004 268 277 (Pubitemid 39298720)
10. S. Connolly, and T.J. Kingsbury Caffeine modulates CREB-dependent gene expression in developing cortical neurons Biochem. Biophys. Res. Commun. 397 2010 152 156
11. O.P. Dall'Igna, L.O. Porciuncula, D.O. Souza, R.A. Cunha, and D.R. Lara Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity Br. J. Pharmacol. 138 2003 1207 1209 (Pubitemid 36543116)
12. K.T. Dineley, M. Westerman, D. Bui, K. Bell, K.H. Ashe, and J.D. Sweatt Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease J. Neurosci. 21 2001 4125 4133 (Pubitemid 32538537)
13. S.B. Dunnett, A. Meldrum, and J.L. Muir Frontal-striatal disconnection disrupts cognitive performance of the frontal-type in the rat Neuroscience 135 2005 1055 1065 (Pubitemid 41416669)
14. V. Echeverria, and A.C. Cuello Intracellular A-beta amyloid, a sign for worse things to come? Mol. Neurobiol. 26 2002 299 316 (Pubitemid 35239806)
15. V. Echeverria, A. Ducatenzeiler, L. Alhonen, J. Janne, S.M. Grant, F. Wandosell, A. Muro, F. Baralle, H. Li, K. Duff, M. Szyf, and A.C. Cuello Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex J. Alzheimers Dis. 6 2004 209 219 (Pubitemid 38823255)
16. V. Echeverria, A. Ducatenzeiler, E. Dowd, J. Janne, S.M. Grant, M. Szyf, F. Wandosell, J. Avila, H. Grimm, S.B. Dunnett, T. Hartmann, L. Alhonen, and A.C. Cuello Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons Neuroscience 129 2004 583 592 (Pubitemid 39487112)
17. V. Echeverria, A. Clerman, and S. Dore Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure Eur. J. Neurosci. 22 2005 2199 2206 (Pubitemid 41653533)
18. V. Echeverria, S. Burgess, J. Gamble-George, R. Zeitlin, X. Lin, C. Cao, and G.W. Arendash Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice Neuroscience 162 4 2009 1220 1231
19. A. Eilers, J. Whitfield, K. Vekrellis, S.J. Neame, B. Shah, and J. Ham c-Jun and Bax: regulators of programmed cell death in developing neurons Biochem. Soc. Trans. 27 1999 790 797 (Pubitemid 30032128)
20. A. Eilers, J. Whitfield, B. Shah, C. Spadoni, H. Desmond, and J. Ham Direct inhibition of c-Jun N-terminal kinase in sympathetic neurones prevents c-jun promoter activation and NGF withdrawal-induced death J. Neurochem. 76 2001 1439 1454 (Pubitemid 32198249)
21. I. Ferrer, R. Blanco, M. Carmona, and B. Puig Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies J. Neural Transm. 108 2001 1397 1415 (Pubitemid 34020445)
22. I. Ferrer, R. Blanco, M. Carmona, R. Ribera, E. Goutan, B. Puig, M.J. Rey, A. Cardozo, F. Vinals, and T. Ribalta Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration Brain Pathol. 11 2001 144 158 (Pubitemid 32198842)
23. S. Finkbeiner, S.F. Tavazoie, A. Maloratsky, K.M. Jacobs, K.M. Harris, and M.E. Greenberg CREB: a major mediator of neuronal neurotrophin responses Neuron 19 1997 1031 1047 (Pubitemid 27512364)
24. A.L. Glotin, A. Calipel, J.Y. Brossas, A.M. Faussat, J. Treton, and F. Mascarelli Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells Invest. Ophthalmol. Vis. Sci. 47 2006 4614 4623 (Pubitemid 46579392)
25. J. Ham, A. Eilers, J. Whitfield, S.J. Neame, and B. Shah c-Jun and the transcriptional control of neuronal apoptosis Biochem. Pharmacol. 60 2000 1015 1021
26. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
27. S.A. Josselyn, and P.V. Nguyen CREB, synapses and memory disorders: past progress and future challenges Curr. Drug Targets CNS Neurol. Disord. 4 2005 481 497 (Pubitemid 41448376)
28. M.E. Kalaitzakis, M.B. Graeber, S.M. Gentleman, and R.K. Pearce Striatal beta-amyloid deposition in Parkinson disease with dementia J. Neuropathol. Exp. Neurol. 67 2008 155 161
29. W.E. Klunk, J.C. Price, C.A. Mathis, N.D. Tsopelas, B.J. Lopresti, S.K. Ziolko, W. Bi, J.A. Hoge, A.D. Cohen, M.D. Ikonomovic, J.A. Saxton, B.E. Snitz, D.A. Pollen, M. Moonis, C.F. Lippa, J.M. Swearer, K.A. Johnson, D.M. Rentz, A.J. Fischman, H.J. Aizenstein, and S.T. DeKosky Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees J. Neurosci. 27 2007 6174 6184 (Pubitemid 46890033)
30. F. Kuperstein, and E. Yavin ERK activation and nuclear translocation in amyloid-beta peptide- and iron-stressed neuronal cell cultures Eur. J. Neurosci. 16 2002 44 54 (Pubitemid 35463596)
31. H.J. Lee, H.S. Cho, E. Park, S. Kim, S.Y. Lee, C.S. Kim, K. Kim do, S.J. Kim, and H.S. Chun Rosmarinic acid protects human dopaminergic neuronal cells against hydrogen peroxide-induced apoptosis Toxicology 250 2008 109 115
32. Z. Liang, F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.X. Gong Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain J. Neurochem. 103 2007 2462 2470 (Pubitemid 350173577)
33. Q.L. Ma, M.E. Harris-White, O.J. Ubeda, M. Simmons, W. Beech, G.P. Lim, B. Teter, S.A. Frautschy, and G.M. Cole Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models J. Neurochem. 103 2007 1594 1607 (Pubitemid 47631821)
34. Q.L. Ma, F. Yang, E.R. Rosario, O.J. Ubeda, W. Beech, D.J. Gant, P.P. Chen, B. Hudspeth, C. Chen, Y. Zhao, H.V. Vinters, S.A. Frautschy, and G.M. Cole Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin J. Neurosci. 29 2009 9078 9089
35. H. Okazawa, and S. Estus The JNK/c-Jun cascade and Alzheimer's disease Am. J. Alzheimers Dis. Other Demen. 17 2002 79 88 (Pubitemid 34754510)
36. C. Otth, A. Mendoza-Naranjo, L. Mujica, A. Zambrano, I.I. Concha, and R.B. Maccioni Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer's disease Neuroreport 14 2003 2403 2409
37. J.J. Pei, E. Braak, H. Braak, I. Grundke-Iqbal, K. Iqbal, B. Winblad, and R.F. Cowburn Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration J. Alzheimers Dis. 3 2001 41 48 (Pubitemid 32238249)
38. J.J. Pei, H. Braak, W.L. An, B. Winblad, R.F. Cowburn, K. Iqbal, and I. Grundke-Iqbal Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease Brain Res. Mol. Brain Res. 109 2002 45 55 (Pubitemid 36078372)
39. G. Perry, H. Roder, A. Nunomura, A. Takeda, A.L. Friedlich, X. Zhu, A.K. Raina, N. Holbrook, S.L. Siedlak, P.L. Harris, and M.A. Smith Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation Neuroreport 10 1999 2411 2415 (Pubitemid 29367948)
40. B. Sahin, S. Galdi, J. Hendrick, R.W. Greene, G.L. Snyder, and J.A. Bibb Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling Brain Res. 1129 2007 1 14 (Pubitemid 46048778)
41. M.J. Savage, Y.G. Lin, J.R. Ciallella, D.G. Flood, and R.W. Scott Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition J. Neurosci. 22 2002 3376 3385 (Pubitemid 37465743)
42. C. Shen, Y. Chen, H. Liu, K. Zhang, T. Zhang, A. Lin, and N. Jing Hydrogen peroxide promotes Abeta production through JNK-dependent activation of gamma-secretase J. Biol. Chem. 283 2008 17721 17730
43. M. Shoji, N. Iwakami, S. Takeuchi, M. Waragai, M. Suzuki, I. Kanazawa, C.F. Lippa, S. Ono, and H. Okazawa JNK activation is associated with intracellular beta-amyloid accumulation Brain Res. Mol. Brain Res. 85 2000 221 233 (Pubitemid 32056254)
44. A.J. Silva, J.H. Kogan, P.W. Frankland, and S. Kida CREB and memory Annu. Rev. Neurosci. 21 1998 127 148 (Pubitemid 28150661)
45. T. Takahashi, K. Morita, R. Akagi, and S. Sassa Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries Curr. Med. Chem. 11 2004 1545 1561 (Pubitemid 38735796)
46. F. Tchantchou, Y. Xu, Y. Wu, Y. Christen, and Y. Luo EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease FASEB J. 21 2007 2400 2408 (Pubitemid 47230670)
47. T. Tully, R. Bourtchouladze, R. Scott, and J. Tallman Targeting the CREB pathway for memory enhancers Nat. Rev. Drug Discov. 2 2003 267 277 (Pubitemid 37361685)
48. A. Wagatsuma, S. Azami, M. Sakura, D. Hatakeyama, H. Aonuma, and E. Ito De Novo synthesis of CREB in a presynaptic neuron is required for synaptic enhancement involved in memory consolidation J. Neurosci. Res. 84 2006 954 960 (Pubitemid 44521039)
49. R. Waltereit, and M. Weller Signaling from cAMP/PKA to MAPK and synaptic plasticity Mol. Neurobiol. 27 2003 99 106 (Pubitemid 36515162)
50. K.M. Webber, M.A. Smith, H.G. Lee, P.L. Harris, P. Moreira, G. Perry, and X. Zhu Mitogen- and stress-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's disease J. Neurosci. Res. 79 2005 554 560 (Pubitemid 40283355)
51. M. Yamamoto-Sasaki, H. Ozawa, T. Saito, M. Rosler, and P. Riederer Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type Brain Res. 824 1999 300 303 (Pubitemid 29225538)
52. H. Zhao, Q. Li, Z. Zhang, X. Pei, J. Wang, and Y. Li Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus Brain Res. 1256 2009 111 122